We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
First Advantage
FA
$4.12B
| $21.5M | 0.01% |
1,654,932
-600,279
| -27% | -$7.84M |
|
977
Ultragenyx Pharmaceutical
RARE
$2.55B
| $21.5M | 0.01% |
464,369
+260,212
| +127% | +$10.2M |
|
978
F5
FFIV
$22.7B
| $21.5M | 0.01% |
149,620
-1,010
| -0.7% | -$148K |
|
979
Perrigo
PRGO
$1.78B
| $21.4M | 0.01% |
628,669
+31,330
| +5% | +$1.1M |
|
|
SVC
980
Service Properties Trust
SVC
$1.07B
| $21.4M | 0.01% |
586,613
-2,992
| -0.5% | -$110K |
|
981
Churchill Downs
CHDN
$6.12B
| $21.4M | 0.01% |
201,986
-205,510
| -50% | -$21.7M |
|
|
DOC
982
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $21.3M | 0.01% |
1,474,806
-393,174
| -21% | -$5.71M |
|
983
Knight Transportation
KNX
$11.4B
| $21.3M | 0.01% |
405,955
-804,716
| -66% | -$41.6M |
|
984
Kosmos Energy
KOS
$1.48B
| $21.3M | 0.01% |
3,343,598
-487,069
| -13% | -$3.04M |
|
985
Helmerich & Payne
HP
$3.71B
| $21.3M | 0.01% |
428,801
-1,265,740
| -75% | -$60.3M |
|
986
Universal Display
OLED
$4.19B
| $21.2M | 0.01% |
196,663
+29,557
| +18% | +$3.1M |
|
987
Chefs' Warehouse
CHEF
$4.5B
| $21.2M | 0.01% |
638,183
+54,765
| +9% | +$1.91M |
|
988
FTI Consulting
FCN
$4.18B
| $21.2M | 0.01% |
133,381
+10,337
| +8% | +$1.73M |
|
989
ABM Industries
ABM
$2.84B
| $21.2M | 0.01% |
476,799
+75,153
| +19% | +$3.3M |
|
990
Avista
AVA
$3.24B
| $21.2M | 0.01% |
477,215
-38,291
| -7% | -$1.53M |
|
991
Insmed
INSM
$28.6B
| $21.1M | 0.01% |
1,056,590
+232,374
| +28% | +$4.49M |
|
992
Nexstar Media Group
NXST
$5.97B
| $21.1M | 0.01% |
120,411
-4,267
| -3% | -$749K |
|
993
News Corp Class A
NWSA
$15.4B
| $21M | 0.01% |
1,155,692
-89,077
| -7% | -$1.55M |
|
994
Plug Power
PLUG
$3.04B
| $21M | 0.01% |
1,699,689
-146,544
| -8% | -$2.33M |
|
995
Boise Cascade
BCC
$3.02B
| $21M | 0.01% |
306,010
-18,951
| -6% | -$1.29M |
|
996
Korn Ferry
KFY
$4.28B
| $21M | 0.01% |
414,355
-47,115
| -10% | -$2.5M |
|
997
Kinsale Capital Group
KNSL
$8.51B
| $20.9M | 0.01% |
80,111
-20,188
| -20% | -$5.82M |
|
998
Prosperity Bancshares
PB
$8.89B
| $20.9M | 0.01% |
287,868
-30,305
| -10% | -$2.19M |
|
999
Sonoco
SON
$5.74B
| $20.9M | 0.01% |
344,220
-2,617
| -0.8% | -$157K |
|
1000
Insperity
NSP
$2.01B
| $20.9M | 0.01% |
183,900
-9,638
| -5% | -$1.09M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.